We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+14.38%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$352M
AUM Growth
+$41.1M
Cap. Flow
+$183K
Cap. Flow %
0.05%
Top 10 Hldgs %
71.31%
Holding
57
New
1
Increased
27
Reduced
11
Closed
10

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.01M
2
AMD icon
Advanced Micro Devices
AMD
+$846K
3
MSFT icon
Microsoft
MSFT
+$460K
4
AMZN icon
Amazon
AMZN
+$382K
5
FIVE icon
Five Below
FIVE
+$243K

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$2.99M
2
URGN icon
UroGen Pharma
URGN
+$606K
3
T icon
AT&T
T
+$358K
4
CLVS
Clovis Oncology, Inc.
CLVS
+$351K
5
EOLS icon
Evolus
EOLS
+$325K

Sector Composition

Rank Sector Weight
1 Technology 33.5%
2 Consumer Discretionary 28.93%
3 Healthcare 22.13%
4 Communication Services 12.42%
5 Industrials 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEE icon
26
NextEra Energy
NEE
$185B
$2.56M 0.73%
35,006
+1,775
+5% +$133K
PRLB icon
27
Protolabs
PRLB
$1.85B
$2.15M 0.61%
23,400
-860
-4% -$84.7K
LLY icon
28
Eli Lilly
LLY
$1.07T
$2.08M 0.59%
9,039
+952
+12% +$191K
EXEL icon
29
Exelixis
EXEL
$14B
$1.33M 0.38%
73,215
-9,515
-12% -$222K
ABT icon
30
Abbott
ABT
$182B
$1.05M 0.3%
9,096
+60
+0.7% +$7K
BMY icon
31
Bristol-Myers Squibb
BMY
$128B
$1.03M 0.29%
15,359
+1,580
+11% +$103K
NSC icon
32
Norfolk Southern
NSC
$77.1B
$990K 0.28%
3,730
+5
+0.1% +$1.38K
AMD icon
33
Advanced Micro Devices
AMD
$807B
$983K 0.28%
+10,468
New +$846K
BA icon
34
Boeing
BA
$167B
$932K 0.26%
3,889
+15
+0.4% +$3.63K
JNJ icon
35
Johnson & Johnson
JNJ
$641B
$827K 0.24%
5,021
+35
+0.7% +$5.79K
COST icon
36
Costco
COST
$422B
$745K 0.21%
1,883
+25
+1% +$9.45K
JPM icon
37
JPMorgan Chase
JPM
$947B
$666K 0.19%
4,279
– –
PFE icon
38
Pfizer
PFE
$141B
$524K 0.15%
13,387
+240
+2% +$9.33K
PAYX icon
39
Paychex
PAYX
$41.1B
$523K 0.15%
4,870
+70
+1% +$7.04K
TGT icon
40
Target
TGT
$63.7B
$517K 0.15%
2,140
– –
DE icon
41
Deere & Co
DE
$169B
$511K 0.15%
1,450
– –
TROW icon
42
T. Rowe Price
TROW
$25.5B
$498K 0.14%
2,515
– –
MRK icon
43
Merck
MRK
$323B
$497K 0.14%
6,392
-212
-3% -$15.8K
NUE icon
44
Nucor
NUE
$56.4B
$420K 0.12%
4,375
– –
CAT icon
45
Caterpillar
CAT
$402B
$369K 0.1%
1,697
– –
DUK icon
46
Duke Energy
DUK
$100B
$259K 0.07%
2,626
– –
VZ icon
47
Verizon
VZ
$198B
$217K 0.06%
3,874
– –
EOLS icon
48
Evolus
EOLS
$407M
– –
-25,000
Closed -$325K
HON icon
49
Honeywell
HON
$77.9B
– –
-1,061
Closed -$217K
IDXX icon
50
Idexx Laboratories
IDXX
$43.9B
– –
-510
Closed -$250K
1
2
3

Similar funds

AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
SCP
Stevens Capital Partners Omaha, Nebraska $416M AUM 18.93% 1-Year Est. Return
VM
Venator Management Pittsburgh, Pennsylvania $416M AUM 16.01% 1-Year Est. Return

Bender Robert & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Bender Robert & Associates held 57 positions worth $352M, up 13% from $311M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Bender Robert & Associates's Q2 2021 filing shows 1 new, 27 increased, 11 reduced and 10 closed positions. Its largest new stake was Advanced Micro Devices: 10,468 shares worth $983K. The largest sale was Alphabet (Google) Class C, an estimated $2.99M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bender Robert & Associates's largest Q2 2021 buy was Advanced Micro Devices: 10,468 shares worth $983K.
  • Bender Robert & Associates added most to Alphabet (Google) Class A in Q2 2021, an estimated $3.01M increase.
  • Bender Robert & Associates's biggest Q2 2021 reduction was Alphabet (Google) Class C, cutting an estimated $2.99M.
  • Bender Robert & Associates fully exited UroGen Pharma in Q2 2021, selling an estimated $606K.
  • Bender Robert & Associates's ten largest holdings make up 71% of its $352M portfolio in Q2 2021.
  • Bender Robert & Associates opened 1 new position and closed 10 in Q2 2021.
  • Bender Robert & Associates's portfolio value rose 13% quarter-over-quarter to $352M.

Based on Bender Robert & Associates's 13F filing for Q2 2021, filed 16 Jul 2021.